Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000630849 | SCV000751818 | likely benign | Fanconi anemia | 2024-01-18 | criteria provided, single submitter | clinical testing | |
St. |
RCV000630849 | SCV001737472 | uncertain significance | Fanconi anemia | 2021-05-20 | criteria provided, single submitter | clinical testing | The FANCA c.2390C>T (p.Ala797Val) missense change has a maximum frequency of 0.036% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/variant/16-89836359-G-A?dataset=gnomad_r2_1). In addition, the variant occurs in the homozygous state one time in gnomAD v2.1.1. Six of seven in silico tools predict a benign effect of this variant on protein function (BP4), but to our knowledge these predictions have not been confirmed by functional assays. The variant has been reported as heterozygous in one individual with head and neck carcinoma occurring before age 50 (PMID: 28678401). To our knowledge, this variant has not been reported in individuals with Fanconi anemia. In summary, this variant meets criteria to be classified as of uncertain significance based on the ACMG/AMP criteria: BP4. |
Genetic Services Laboratory, |
RCV001821773 | SCV002065244 | uncertain significance | not specified | 2019-11-22 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000630849 | SCV002534951 | uncertain significance | Fanconi anemia | 2021-11-05 | criteria provided, single submitter | curation | |
Gene |
RCV002461940 | SCV002757146 | uncertain significance | not provided | 2022-05-24 | criteria provided, single submitter | clinical testing | Reported in a patient with oropharynx carcinoma who also harbors an additional FANCA variant; however, detailed clinical information was not provided (Chandrasekharappa et al., 2017); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: Zahra2020[research], 28678401) |
Natera, |
RCV001271599 | SCV001452866 | uncertain significance | Fanconi anemia complementation group A | 2020-09-16 | no assertion criteria provided | clinical testing | |
Genome |
RCV001271599 | SCV004037535 | not provided | Fanconi anemia complementation group A | no assertion provided | phenotyping only | Variant classified as Uncertain significance and reported on 06-13-2019 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. |